Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) CEO Vininder Singh sold 7,245 shares of the business’s stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $1.61, for a total transaction of $11,664.45. Following the completion of the sale, the chief executive officer now owns 2,385,201 shares in the company, valued at $3,840,173.61. The trade was a 0.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Vininder Singh also recently made the following trade(s):
- On Thursday, April 3rd, Vininder Singh sold 27,958 shares of Bullfrog AI stock. The stock was sold at an average price of $1.44, for a total transaction of $40,259.52.
Bullfrog AI Stock Down 7.8 %
BFRG opened at $1.30 on Friday. The business has a fifty day simple moving average of $2.28 and a 200-day simple moving average of $2.34. The firm has a market cap of $12.24 million, a PE ratio of -1.53 and a beta of 0.33. Bullfrog AI Holdings, Inc. has a fifty-two week low of $1.23 and a fifty-two week high of $4.84.
Institutional Trading of Bullfrog AI
Large investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new stake in shares of Bullfrog AI in the fourth quarter worth $30,000. Geode Capital Management LLC lifted its stake in Bullfrog AI by 31.0% in the 4th quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock worth $94,000 after acquiring an additional 11,140 shares in the last quarter. Finally, Two Sigma Securities LLC acquired a new stake in Bullfrog AI during the 4th quarter worth about $41,000. 0.96% of the stock is owned by institutional investors and hedge funds.
Bullfrog AI Company Profile
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Featured Stories
- Five stocks we like better than Bullfrog AI
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Find Undervalued Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What Are Earnings Reports?
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.